相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway
Zhan-zhao Liu et al.
LIFE SCIENCES (2022)
Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy
Yikai Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2022)
Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
Seshagiri Rao Nandula et al.
CARDIOVASCULAR DIABETOLOGY (2021)
FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK/NAD plus -dependent manner
Qiaoxia Dai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Akt/GSK3β/Nrf2/HO-1 pathway activation by flurbiprofen protects the hippocampal neurons in a rat model of glutamate excitotoxicity
Fatma Farhat et al.
NEUROPHARMACOLOGY (2021)
Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function
Xiaozhen Dai et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial
Anne-Marie Langmach Wegeberg et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Henrik Svanstrom et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Sitagliptin-mediated preservation of endothelial progenitor cell function via augmenting autophagy enhances ischaemic angiogenesis in diabetes
Xiaozhen Dai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial
Subodh Verma et al.
CIRCULATION (2018)
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ss/Fyn pathway
Ying Xin et al.
REDOX BIOLOGY (2018)
Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Results From the LEADER Trial
Johannes F. E. Mann et al.
CIRCULATION (2018)
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial
Subodh Verma et al.
CIRCULATION (2018)
A Novel CXCR4 antagonist enhances angiogenesis via modifying the ischaemic tissue environment
Xiaoqing Yan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes
Julien Wils et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
Hideki Kushima et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia
Xiaozhen Dai et al.
CIRCULATION RESEARCH (2017)
Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice
Jia-Wen Yu et al.
CARDIOVASCULAR DIABETOLOGY (2016)
The Cardiovascular Biology of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2016)
Liraglutide protects cardiac microvascular endothelial cells against hypoxiaireoxygenation injury through the suppression of the SR-Ca2+-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways
Ying Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways
Lili Shi et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
Marina Romani-Perez et al.
ENDOCRINOLOGY (2015)
Nrf2 Regulates Angiogenesis: Effect on Endothelial Cells, Bone Marrow-Derived Proangiogenic Cells and Hind Limb Ischemia
Urszula Florczyk et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Dysfunction of Endothelial Progenitor Cells under Diabetic Conditions and its Underlying Mechanisms
Kyeong-A Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
Gian Paolo Fadini et al.
CIRCULATION RESEARCH (2012)
Strategies to Reverse Endothelial Progenitor Cell Dysfunction in Diabetes
Alessandra Petrelli et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Chemokine receptor CXCR7 mediates human endothelial progenitor cells survival, angiogenesis, but not proliferation
Xiaoqing Yan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
The effect of glucagon-like peptide 1 on cardiovascular risk
Jacob Sivertsen et al.
NATURE REVIEWS CARDIOLOGY (2012)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2
Saher Hamed et al.
CARDIOVASCULAR RESEARCH (2011)
Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression
James W. Kaspar et al.
FASEB JOURNAL (2011)
The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells
Xiaozhen Dai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes Possible role of stromal-derived factor-1α
Gian Paolo Fadini et al.
DIABETES CARE (2010)
Endothelial progenitor cells and cardiovascular homeostasis: Clinical implications
Giulio Pompilio et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels
Hongwei Shao et al.
STEM CELLS (2008)
Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart
Hyun-Jai Cho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/akt-dependent activation of Nrf2
Guohao Dai et al.
CIRCULATION RESEARCH (2007)
Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus -: Restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
Sajoscha A. Sorrentino et al.
CIRCULATION (2007)
Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function
MJ Callaghan et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Endothelial progenitor cell dysfunction - A novel concept in the pathogenesis of vascular complications of type 1 diabetes
CJM Loomans et al.
DIABETES (2004)
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
JM Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium
H Kamihata et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Statin therapy accelerates reendothelialization - A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells
DH Walter et al.
CIRCULATION (2002)
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
M Vasa et al.
CIRCULATION RESEARCH (2001)
Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization
T Murohara et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)